A
APPLIED DNA SCIENCES INC — Investor Relations & Filings
Filings indexed
1,014
across all filing types
Latest filing
2016-07-22
Regulatory Filings
Country
US
United States of America
Listing
US
APDN
Applied DNA Sciences Inc. is a biotechnology company focused on the development and manufacture of DNA-based technologies for genetic medicine. The company's core expertise lies in polymerase chain reaction (PCR) and large-scale, cell-free enzymatic DNA synthesis. Its primary offering is lineaDNA™, a proprietary, linear form of DNA that serves as an alternative to plasmid DNA. This technology is designed for use in advanced therapeutic modalities, including the production of mRNA for vaccines and therapies, as well as for gene and cell therapies. Additionally, the company provides molecular and genomic diagnostic testing services through a clinical laboratory subsidiary.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K (AMENDMENT NO. 1) | 2016-07-22 | English | |
| FORM 8-K | 2016-06-09 | English | |
| FORM 10-Q | 2016-05-12 | English | |
| FORM 8-K | 2016-05-12 | English | |
| DEFINITIVE ADDITIONAL MATERIALS | 2016-04-21 | English | |
| SCHEDULE 14A | 2016-04-21 | English |
Browse filings by year
23 years- 2026 10 filings
- 2025 61 filings
- 2024 79 filings
- 2023 35 filings
- 2022 38 filings
- 2021 46 filings
- 2020 50 filings
- 2019 89 filings
- 2018 51 filings
- 2017 40 filings
- 2016 37 filings
- 2015 51 filings
- 2014 56 filings
- 2013 22 filings
- 2012 15 filings
- 2011 18 filings
- 2010 16 filings
- 2009 36 filings
- 2008 30 filings
- 2007 39 filings
- 2006 46 filings
- 2005 71 filings
- 2004 78 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2016
11 filings
| |||||
| 9462286 | FORM 8-K (AMENDMENT NO. 1) | 2016-07-22 | English | ||
| 9462288 | FORM 8-K | 2016-06-09 | English | ||
| 9462292 | FORM 10-Q | 2016-05-12 | English | ||
| 9462293 | FORM 8-K | 2016-05-12 | English | ||
| 9462294 | DEFINITIVE ADDITIONAL MATERIALS | 2016-04-21 | English | ||
| 9462296 | SCHEDULE 14A | 2016-04-21 | English | ||
| 9462297 | SCHEDULE 13G (AMENDMENT NO. 2) | 2016-03-15 | English | ||
| 9462298 | FORM 4 | 2016-03-15 | English | ||
| 9462299 | SCHEDULE 13G AMENDMENT NO. 1 | 2016-02-11 | English | ||
| 9462301 | FORM 10-Q | 2016-02-10 | English | ||
| 9462302 | FORM 8-K | 2016-02-10 | English | ||
|
2015
4 filings
| |||||
| 9462303 | FORM 4 | 2015-12-24 | English | ||
| 9462304 | FORM 4 | 2015-12-24 | English | ||
| 9462306 | FORM 4 | 2015-12-24 | English | ||
| 9462307 | FORM 4 | 2015-12-24 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
APPLIED DNA SCIENCES INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35347/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35347 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35347 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35347 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35347}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for APPLIED DNA SCIENCES INC (id: 35347)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.